Cidara Therapeutics Inc
F:20D0
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cidara Therapeutics Inc
F:20D0
|
US |
|
C
|
Carlisle Companies Inc
F:CLE
|
US |
|
A
|
Alaska Air Group Inc
XMUN:ALK
|
US |
|
T
|
Tompkins Financial Corp
AMEX:TMP
|
US |
|
A
|
ANI Pharmaceuticals Inc
F:BSFA
|
US |
|
P
|
Pitney Bowes Inc
F:PBW
|
US |
|
C
|
CAC Holdings Corp
F:CB4
|
JP |
|
V
|
Vinci SA
F:SQUA
|
FR |
|
Sutro Biopharma Inc
NASDAQ:STRO
|
US |
|
Microstrategy Inc
BMV:MSTR
|
US |
|
Sunlands Technology Group
F:S790
|
CN |
|
Time Out Group PLC
F:05T
|
UK |
|
Bank of China Ltd
F:W8VS
|
CN |
|
Tocvan Ventures Corp
F:TV3
|
CA |
|
S
|
SoftBank Group Corp
XMUN:SFT
|
JP |
|
W
|
Wells Fargo & Co
XMUN:NWT
|
US |
|
F
|
F5 Inc
F:FFV
|
US |
|
S
|
Stratasys Ltd
F:SCY
|
US |
|
C
|
China Travel International Investment Hong Kong Ltd
F:CTI
|
HK |
|
Doximity Inc
NYSE:DOCS
|
US |
|
P
|
Prada SpA
XMUN:PRP
|
IT |
|
B
|
BioPlus Co Ltd
KOSDAQ:099430
|
KR |
|
O
|
Old National Bancorp
F:ON1
|
US |
Intrinsic Value
There is not enough data to reliably calculate the intrinsic value for Cidara Therapeutics Inc.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Cidara Therapeutics Does
Cidara Therapeutics, Inc. is a biotechnology company, which engages in the discovery, development, and commercialization of novel anti-infectives. The company is headquartered in San Diego, California and currently employs 89 full-time employees. The company went IPO on 2015-04-15. The firm is focused on the discovery, development and commercialization of therapeutics designed for the care of patients facing serious fungal or viral infections.
- Headquarters
- United States of America US
- Employees
- 89
- IPO date
- Apr 15, 2015
Cidara Therapeutics has no economic moat
Cidara Therapeutics Inc lacks an economic moat, leaving it vulnerable to competitive pressures and market challenges.
Read the full moat analysis
